Page 221 - Multidisipliner Covid 19
P. 221

COVID-19 Tedavi Stratejileri


                   11. Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown
                      apparent efficacy in treatment of COVID-19 associated pneumonia in
                      clinical studies. Biosci Trends. 2020; 14(1):72-73. doi:10.5582/bst.2020.
                      010479.
                   12. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithro-
                      mycin as a treatment of COVID-19: results of an open-label non rand-
                      omized clinical trial. Int J Antimicrob Agents. 2020; 105949.doi:10.1016/
                      j.ijantimicag.2020.105949.
                   13. Chen Z, Hu J, Zhang Z, et al. Efficacy of hydroxychloroquine in patients
                      with COVID-19: results of a randomized clinical trial. medrxiv.2020;03
                      (22):20040758.
                   14. Chen J, Liu D, Liu L, et al. A pilot study of hydroxychloroquine in treat-
                      ment of patients with common coronavirus disease-19 (COVID-19). J
                      Zhejiang Univ (Med Sci). 2020;49(2): 215-219. doi:10.3785/j.issn.1008-
                      9292.2020.03.03.
                   15. Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloro-
                      quine usage in United States veterans hospitalized with Covid-19.
                      medrxiv. 2020;04(16):20065920.
                   16. Borba MGS, Val FFA, Sampaio VS, et al. Chloroquine diphosphate in
                      two different dosages as adjunctive therapy of hospitalized patients
                      with severe respiratory syndrome in the context of coronavirus (SARS-
                      CoV-2) infection: preliminary safety results of a randomized, double-
                      blinded, phase IIb clinical trial (CloroCovid-19 study). medRxiv. 2020.
                      https://www. medrxiv.org/content/10.1101/2020.04.07.20056424v
                      1.full.pdf
                   17. Mahevas M, Tran V-T, Roumier M, et al. No evidence of clinical efficacy
                      of hydroxychloroquine in patients hospitalized for COVID-19 infection
                      with oxygen requirement: results of a study using routinely collected
                      data to emulate a target trial. medrxiv. 2020;04(10): 20060699.
                   18. Perinel S, Launay M, Botelho-Nevers E_, et al. Towards Optimization
                      of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Pati-
                      ents. Clin Infect Dis. 2020;ciaa394. https://doi.org/10.1093/ cid/ciaa394.
                   19. Schrezenmeier E, Dorner T. Mechanisms of action of hydroxychloro-
                      quine and chloroquine: implications for rheumatology. Nat Rev Rheu-
                      matol. 2020;16(3):155–66.
                   20. Multicenter collaboration group of Department of S, Technology of
                      Guangdong P. Health Commission of Guangdong Province for chlo-




                       220
   216   217   218   219   220   221   222   223   224   225   226